Clinical Trial

ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome

Name: ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome — clinical trial record (NCT07531745)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

The primary purpose of this study is to evaluate the safety and tolerability of ION337 in participants with Dravet syndrome (DS).

Protocol Amendment History 1 change

critical Recruitment opened 2026-04-22

Trial Details

NCT Number	NCT07531745
Lead Sponsor	Ionis Pharmaceuticals, Inc.
Conditions	Dravet Syndrome
Enrollment	32 participants
Start Date	2026-05-21
Primary Completion	2030-12 (estimated)
Study Completion	2030-12 (estimated)
Updated on ClinicalTrials.gov	2026-08-05